MODIFICATION OF THE INDUCTION OF BCGcw SUPPRESSOR CELLS BY MITOMYCIN C1

[1]  M. Mokyr,et al.  Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide. , 1983, Cancer research.

[2]  R. North.  Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells , 1982, The Journal of experimental medicine.

[3]  N. Takeichi,et al.  Enhancement of antitumor transplantation resistance in rats by appropriately timed administration of busulfan. , 1981, Cancer research.

[4]  M. Mokyr,et al.  Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors. , 1981, Cancer research.

[5]  D. Lannin,et al.  Effect of cyclophosphamide on mice bearing methylcholanthrene-induced fibrosarcomas. , 1980, Cancer research.

[6]  H. Kobayashi,et al.  Potentiation of concanavalin A-bound L1210 vaccine in vivo by chemotherapeutic agents. , 1978, Cancer research.

[7]  F. Sendo,et al.  Spontaneous regression of syngeneic transplanted tumors in rats pretreated with the antileukemia drug busulfan. , 1978, Journal of the National Cancer Institute.

[8]  H. Morris,et al.  Enhancement of tumor growth following immunization with Bacillus Calmette-Guérin cell walls. , 1976, Cancer research.

[9]  M. Kaliner,et al.  Antibody-dependent lymphocyte mediated cytotoxicity mechanism and modulation by cyclic nucleotides. , 1975, Cellular immunology.

[10]  G. Steele,et al.  Effects of cyclophosphamide on immunity against chemically‐induced syngeneic murine sarcomas , 1974, International journal of cancer.